Management of Barrett's esophagus with low-grade dysplasia

被引:7
作者
Harrison, M. [1 ,2 ]
Allen, J. E. [1 ,2 ]
Gorrepati, V. S. [3 ]
Lopez-Jamar, J. M. E. [4 ]
Sharma, P. [3 ]
机构
[1] Univ Kansas, Sch Med, Dept Internal Med, Kansas City, MO USA
[2] Vet Affairs Med Ctr, Kansas City, MO USA
[3] Dept Vet Affairs Med Ctr, Dept Gastroenterol, Kansas City, MO USA
[4] Hosp Clin San Carlos, Unidad Endoscopia, Madrid, Spain
来源
DISEASES OF THE ESOPHAGUS | 2018年 / 31卷 / 04期
关键词
Barrett's esophagus; confirmed low-grade dysplasia; endoscopic treatment for low-grade dysplasia; esophageal cancer; persistent low-grade dysplasia; progression; RADIOFREQUENCY ABLATION; NEOPLASTIC PROGRESSION; INCREASED RISK; DISEASE PROGRESSION; MALIGNANT PROGRESSION; ADENOCARCINOMA; DIAGNOSIS; P53; METAANALYSIS; OVEREXPRESSION;
D O I
10.1093/dote/doy004
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Barrett's esophagus progresses to esophageal adenocarcinoma in a stepwise histological fashion of no dysplasia, low grade dysplasia, high grade dysplasia and cancer. Hence the progression to cancer from various histological stages is different. Progression to cancer from low grade dysplasia is highly variable in the literature due to high inter-observer variability between pathologists in diagnosing it. Studies have shown the utility of having confirmation of low grade dysplasia by expert pathologists or documenting its persistence on two subsequent endoscopies in order to unify the diagnosis. The treatment of low grade dysplasia is variable. In this article we summarize the diagnosis, evaluation and management of low grade dysplasia in Barrett's Esophagus
引用
收藏
页数:5
相关论文
共 49 条
  • [1] Abela JE, 2008, AM J GASTROENTEROL, V103, P2402, DOI 10.1111/j.1572-0241.2007.01746.x
  • [2] Prospective study of cyclin D1 overexpression in Barrett's esophagus: Association with increased risk of adenocarcinoma
    Bani-Hani, K
    Martin, IG
    Hardie, LJ
    Mapstone, N
    Briggs, JA
    Forman, D
    Wild, CP
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (16) : 1316 - 1321
  • [3] Population-Based Study Reveals New Risk-Stratification Biomarker Panel for Barrett's Esophagus
    Bird-Lieberman, Elizabeth L.
    Dunn, Jason M.
    Coleman, Helen G.
    Lao-Sirieix, Pierre
    Oukrif, Dahmane
    Moore, Christina E.
    Varghese, Sibu
    Johnston, Brian T.
    Arthur, Kenneth
    McManus, Damian T.
    Novelli, Marco R.
    O'Donovan, Maria
    Cardwell, Christopher R.
    Lovat, Laurence B.
    Murray, Liam J.
    Fitzgerald, Rebecca C.
    [J]. GASTROENTEROLOGY, 2012, 143 (04) : 927 - +
  • [4] Spatial Predisposition of Dysplasia in Barrett's Esophagus Segments: A Pooled Analysis of the SURF and AIM Dysplasia Trials
    Cotton, Cary C.
    Duits, Lucas C.
    Wolf, W. Asher
    Peery, Anne F.
    Dellon, Evan S.
    Bergman, Jacques J.
    Shaheen, Nicholas J.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 (10) : 1412 - 1419
  • [5] Low-Grade Dysplasia in Barrett's Esophagus: Overdiagnosed and Underestimated
    Curvers, Wouter L.
    ten Kate, Fiebo J.
    Krishnadath, Kausilia K.
    Visser, Mike
    Elzer, Brenda
    Baak, Lubertus C.
    Bohmer, Clarisse
    Mallant-Hent, Rosalie C.
    van Oijen, Arnout
    Naber, Anton H.
    Scholten, Pieter
    Busch, Olivier R.
    Blaauwgeers, Harriet G. T.
    Meijer, Gerrit A.
    Bergman, Jacques J. G. H. M.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (07) : 1523 - 1530
  • [6] Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study
    de Jonge, Pieter J. F.
    van Blankenstein, Mark
    Looman, Caspar W. N.
    Casparie, Mariel K.
    Meijer, Gerrit A.
    Kuipers, Ernst J.
    [J]. GUT, 2010, 59 (08) : 1030 - 1036
  • [7] Patients With Barrett's Esophagus and Confirmed Persistent Low-Grade Dysplasia Are at Increased Risk for Progression to Neoplasia
    Duits, Lucas C.
    van der Wel, Myrtle J.
    Cotton, Cary C.
    Phoa, K. Nadine
    ten Kate, Fiebo J. W.
    Seldenrijk, Cees A.
    Offerhaus, G. Johan A.
    Visser, Mike
    Meijer, Sybren L.
    Mallant-Hent, Rosalie C.
    Krishnadath, Kausilia K.
    Pouw, Roos E.
    Tijssen, Jan G. P.
    Shaheen, Nicholas J.
    Bergman, Jacques J. G. H. M.
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : 993 - +
  • [8] Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel
    Duits, Lucas C.
    Phoa, K. Nadine
    Curvers, Wouter L.
    ten Kate, Fiebo J. W.
    Meijer, Gerrit A.
    Seldenrijk, Cees A.
    Offerhaus, G. Johan
    Visser, Mike
    Meijer, Sybren L.
    Krishnadath, Kausilia K.
    Tijssen, Jan G. P.
    Mallant-Hent, Rosalie C.
    Bergman, Jacques J. G. H. M.
    [J]. GUT, 2015, 64 (05) : 700 - 706
  • [9] British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus
    Fitzgerald, Rebecca C.
    di Pietro, Massimiliano
    Ragunath, Krish
    Ang, Yeng
    Kang, Jin-Yong
    Watson, Peter
    Trudgill, Nigel
    Patel, Praful
    Kaye, Philip V.
    Sanders, Scott
    O'Donovan, Maria
    Bird-Lieberman, Elizabeth
    Bhandari, Pradeep
    Jankowski, Janusz A.
    Attwood, Stephen
    Parsons, Simon L.
    Loft, Duncan
    Lagergren, Jesper
    Moayyedi, Paul
    Lyratzopoulos, Georgios
    de Caestecker, John
    [J]. GUT, 2014, 63 (01) : 7 - 42
  • [10] Risk stratification for malignant progression in Barrett's esophagus: Gender, age, duration and year of surveillance
    Gatenby, Piers
    Bhattacharjee, Santanu
    Wall, Christine
    Caygill, Christine
    Watson, Anthony
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (48) : 10592 - 10600